Navigation Links
EUCODIS Bioscience Achieves Development Milestone in Second Collaboration With Lohmann Animal Health
Date:6/18/2009

VIENNA, Austria, and CUXHAVEN, Germany, June 18 /PRNewswire/ -- EUCODIS Bioscience, a company developing, manufacturing, and marketing enzymes and other proteins for the chemical industry, announced today that it has achieved an important milestone in the development of an undisclosed protein for Lohmann Animal Health (LAH), a leading provider of feed components and vaccines for farm animals. This achievement triggered a milestone payment from LAH to EUCODIS Bioscience.

EUCODIS Bioscience is developing an innovative protein that LAH plans to use as the active ingredient of a new product line. EUCODIS Bioscience and LAH currently have two development agreements in place. In February, EUCODIS Bioscience announced the achievement of a development milestone pertaining to a separate agreement with LAH.

"We have made significant progress in developing a protein showing innovative properties that will bring significant value for agricultural applications," said Rudy Pandjaitan, PhD, CEO of EUCODIS Bioscience. "We are excited about this project, as the product we are developing for our partner LAH has the potential to open a new market in the food and feed industry."

About EUCODIS Bioscience

EUCODIS Bioscience GmbH develops, manufactures, and markets industrial enzymes.

EUCODIS Bioscience' products help customers in the chemical, pharmaceutical, and food and feed industries to make manufacturing processes more efficient and cleaner, and to generate products with superior properties.

EUCODIS Bioscience originally focused on developing enzymes for industrial partners, including GlaxoSmithKline, Henkel, and Lohmann Animal Health. Since 2009, the Company also markets its own products.

Led by an experienced management team, EUCODIS Bioscience is backed by Austrian and German institutional venture capital funds, founders, and private investors. The Com
'/>"/>

SOURCE EUCODIS Bioscience
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)SALT LAKE CITY, Dec. 4 Dynatronics Corporation (Nasdaq: DYNT ) announced it has signed a sole-source vendor agreement to provide therapy equipment and rehab supplies to Benchmark Physical Therapy wi
(Date:12/4/2009)Opposes use of imported drugs often stored in tin cans and car trunks ,, WASHINGTON, Dec. 4 Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encomp
(Date:12/4/2009)MORRISTOWN, N.J., Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ), a leading global specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed
Breaking Medicine Technology:RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday October 29 2009 5302 1AMN Healthcare Services to Host 2009 Third Quarter Earnings Conference Call on Thursday October 29 2009 5302 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 1CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 2CPhI 2009 3A Madrid Launch for BioPh Marks Pharma and Biotech Convergence 5300 3Liver Cancer Patients May Get Hope 59093 1Liver Cancer Patients May Get Hope 59093 2
(Date:12/4/2009)SCOTTSDALE, Ariz., Dec. 4 Healthcare Trust of America, Inc. ("HTA"), a self-managed, non-traded, real estate investment trust, announced the execution of a purchase and sale agreement to acquire a th
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)Working with mice, scientists at Johns Hopkins publishing in the December issue of Neoplasia have shown that a protein made by a gene called "Twist" may be the proverbial red flag that can accuratel
Breaking Medicine News(10 mins):Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3
...new genetic risk factors for rheumatoid arthritis ... risk factors identified so far have been associat...out two-thirds of RA patients, but distinguishing ... of Leiden University Medical Center in The Nether...
...search for Usability Evaluation of HIT Providers ,...eed for understanding the usability of Electronic ...tric.com ) launches the first syndicated user per...n now is usability. Up to now the focus for compar...
...k, but human application is unclear , , TU... put down that protein shake -- at least if you,re...n protein spell trouble for rats that already eat ... about protein in the development of diabetes, sai...
...pectation may be factors in helping older adults r...n, say researchers with the Birmingham Veterans Ad... Alabama at Birmingham). In findings published in ... and more completely than did patients hospitalize...
... Cross Blue Shield of Georgia (BCBSGa) announced t...t rate for clinical psychologists by approximately...your auto mechanic or home handyman per hour. , ...al psychologists were reimbursed by BCBSGa nearl...
... Vision Screenings , , SAN ANTONIO, April 7 Sa...Vision eye care professionals are teaming up with ...ter to provide free vision screenings for children...tion and a free pair of eyeglasses from participat...
Other Medicine News:Health News:Genetic risk factors play role in autoantibody-negative rheumatoid arthritis 2Health News:EMRs Put to the Test on Usability 2Health News:EMRs Put to the Test on Usability 3Health News:Protein Might Be a Troublesome Nutrient 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 2Health News:VA/UAB study looks at functional decline in older patients after hospitalization 3Health News:Blue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological Association 2Health News:Blue Cross Blue Shield of Georgia Is Skimping on Mental Health Care, Says Georgia Psychological Association 3Health News:Local EyeMasters Stores and Davis Vision to Team Up with San Antonio Spurs 2
English & Spanish Medical Words & Phrases, 3rd Ed.
PocketBilling©
BluefishRx ICD-9 2005 Coding Tool
MD Coder Pocket PC 2006
Medicine Products: